RSS-Feed abonnieren
DOI: 10.1055/s-0038-1629630
Survey of 1725 Bone Scans in Patients with Malignant Disease with Particular Emphasis on Carcinoma of the Breast
Publikationsverlauf
Received:
31. März 1992
Publikationsdatum:
04. Februar 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00034924/199206/lookinside/thumbnails/10-1055-s-0038-1629630-1.jpg)
Summary
1725 bone scans, done for evaluation of metastatic involvement from malignant neoplasms, were reviewed. The fraction of positive scans (multiple lesions in the bone scan) was 34% of the patients with different malignancies. In 251 patients (12%) a single bone lesion was detected and 114 of these patients were followed-up and re-scanned once or twice within 1 to 4 years. 39 of the 93 patients with solitary bone lesion who on follow-up developed multiple lesions had carcinoma of the breast as the primary.
Zusammenfassung
Es wurden 1725 Skelettszintigramme, die zur Metastasensuche bei Malignomen vorgenommen worden waren, retrospektiv analysiert. Der Prozentsatz pathologischer Szintigramme (multiple Herde) betrug 34% der Patienten, die unterschiedliche Malignome aufwiesen. Bei 251 Patienten (12%) war ein solitärer Skelettherd festgestellt worden. Von diesen Patienten waren 114 innerhalb von 1 bis 4 Jahren ein- oder zweimal szintigraphisch nachuntersucht worden. 39 von 93 Patienten mit solitären Knochenherden, die im Verlauf multiple Läsionen entwickelten, wiesen als Primärtumor ein Mammakarzinom auf.
-
REFERENCES
- 1 Ahmed A, Glynne-Jones R, Ell PJ. Skeletal scintigraphy in carcinoma of the breast – a ten-year retrospective study of 389 patients. Nucl Med Commun 1990; 11: 421-6.
- 2 Baker FR, Holmes ER, Alderson PO. et al. An evaluation of bone scans as screening procedure for occult metastases in primary breast cancer. Ann Surg 1977; 186: 363-8.
- 3 Belliveau RE, Spencer RP. Incidence and sites of bone lesion detected by 99mTc polyphosphate scans in patients with tumours. Cancer 1975; 36: 259-63.
- 4 Citrin DL, Furnival CM, Bessent RG. et al. Radioactive technetium phosphate bone scanning in pre-operative assessment and follow-up study of patients with primary cancer of breast. Surg Gyn Obstet 1976; 143: 360-4.
- 5 Collins JD, Basset L, Main GD, Kagan C. Percutaneous biopysy following positive bone scans. Radiology 1979; 132: 439-42.
- 6 Corcoran RJ, Thrall JH, Kyle RW. et al. Solitary abnormalities in bone scans of patients with extraosseous malignancies. Radiology 1976; 121: 663-7.
- 7 Davies CJ, Criffiths PA, Preston BJ. et al. Staging breast cancer: role of scanning. Br Med J 1980; ii: 603-5.
- 8 Derimanov SG. »For« and »against« bone scintigraphy of patients with breast cancer. Nucl Med Commun 1987; 08: 79-86.
- 9 Ell PJ, Dixon JH, Abdullah AZ. Unusual spread of juxtacortical osteosarcoma. J Nucl Med 1980; 21: 90-1.
- 10 Fogelman I. Diphosphonate bone scanning agents – current concepts. Eur J Nucl Med 1982; 07: 509-9.
- 11 Galasko CS, Sylvester BS. Back pain in patients treated for malignant tumours. Clin Oncol 1978; 04: 273-83.
- 12 Galasko CSB. The anatomy and pathways of skeletal metastases. In: Bone metastases. Weiss L, Gilbert HA. eds. Boston: Hall; 1981: 49-63.
- 13 Gerber FH, Goodreau JJ, Kirchner PT. et al. Efficacy of pre-operative and postoperative scanning in the management of breast carcinoma. N Engl J Med 1977; 297: 300-3.
- 14 Giatto S, Pacini P, Azzini V. et al. Preoperative staging of primary breast cancer: a multicentre study. Cancer 1988; 61: 1038-40.
- 15 McNeil BJ, Pace PD, Gray EB, Adelstein SJ, Wilson RE. Preoperative and follow-up bone scans in patients with primary carcinoma of the breast. Surg Gynecol Obstet 1978; 147: 745-8.
- 16 Merrick MV. Bone scanning. Br J Radiol 1975; 48: 327-51.
- 17 Shirezi PH, Rayudu GV, Fordham EW. Review of solitary F-18 bone scan lesions. Radiology 1974; 112: 369-72.
- 18 Tofe AJ, Francis MD, Harvey WJ. Correlation of neoplasms with incidence and localization of skeletal metastases. J Nucl Med 1975; 16: 989-9.
- 19 Tumeh SS, Beadle G, Kaplan MD. Clinical significance of solitary rib lesions in patients with extraskeletal malignancy. J Nucl Med 1985; 26: 1140-3.